Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.
Mohamed YI, Lee S, Xiao L, Hassan MM, Qayyum A, Hiatia R, Pestana RC, Haque A, George B, Rashid A, Duda DG, Elghazaly H, Wolff RA, Morris JS, Yao J, Amin HM, Kaseb AO.
Mohamed YI, et al. Among authors: yao j.
Oncotarget. 2021 Apr 13;12(8):756-766. doi: 10.18632/oncotarget.27924. eCollection 2021 Apr 13.
Oncotarget. 2021.
PMID: 33889299
Free PMC article.